Variations in anxiolytic and hypnotic prescribing by GPs: a cross-sectional analysis using data from the UK Quality and Outcomes Framework
Authors:
Open Access
- 1 June 2009
- journal article
- research article
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 59 (563) , e191-e198
Abstract
Background Wide variations in anxiolytic and hypnotic prescribing by GPs in England have been described, but are largely unexplained. Aim To examine the relationships between the volume of anxiolytics and hypnotics prescribed by GPs and their practice characteristics, population demography, and performance indicators. Design of study Cross-sectional study. Setting All general practices in England. Methods A dataset was constructed for 8469 (98.8%) general practices including: standardised prescribing volume data for anxiolytics and hypnotics (average daily quantities per 1000 STAR-PUs [Specific Therapeutic group Age-sex weightings Related Prescribing Units]), practice descriptors, Index of Multiple Deprivation 2004, ethnicity data (2001 UK Census), and Quality and Outcomes Framework (QOF) data. Results The standardised volume of anxiolytics and hypnotics prescribed varied eightfold between practices on the 5th and 95th centiles. A regression model was constructed which explained 20.5% of the variation. Higher prescribing practices were located in more deprived areas (standardised β 0.31), but also in areas with a lower proportion of ethnic minorities (black or black British = −0.22; Asian or Asian British = −0.12). Higher volumes were also prescribed by practices with lower QOF scores (‘Clinical Care’ domain = −0.12; ‘Organisational’ domain = −0.08). Other significant but weaker predictors were: lower proportions of female GPs, higher recorded prevalence of serious mental illness and non-training status. The proportion of GPs trained outside UK was not a predictor. Conclusion Demographic factors were more powerful determinants of prescribing than characteristics of the practice itself. Nevertheless, the findings provide some support for the notion that high prescribing practices were less well developed, in that their QOF scores were lower and they were less likely to be training practices.Keywords
This publication has 35 references indexed in Scilit:
- The impact of co-morbidity on GPs' pharmacological treatment decisions for patients with an anxiety disorderFamily Practice, 2007
- Diabetes, Common Mental Disorders, and Disability: Findings From the UK National Psychiatric Morbidity SurveyPsychosomatic Medicine, 2007
- Prescribing benzodiazepines in general practice: a new view of an old problemHealth: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, 2007
- Explaining variation in antidepressant prescribing rates in east London: a cross sectional studyFamily Practice, 2004
- Common mental disorders and ethnicity in England: the EMPIRIC StudyPsychological Medicine, 2004
- Benzodiazepines in primary health care: a survey of general practitioners prescribing patternsAddiction, 1996
- Benzodiazepine prescribing in general practice: dispelling some mythsFamily Practice, 1995
- Benzodiazepine Prescribing and Withdrawal for 3234 Patients in 15 General PracticesFamily Practice, 1994
- Factors Linked to the Prescribing of Benzodiazepines by General Practice Principals and TraineesFamily Practice, 1992
- Ethnic differences in consultation rates in urban general practice.BMJ, 1989